There is growing excitement around the prospect of an approved COVID-19 vaccine. Two vaccines are currently being evaluated by the Food and Drug Administration (FDA). Pfizer was approved Friday and Moderna will be reviewed this week. States are eagerly tackling distribution plans – debating the most effective way to get vaccines out. Those plans start with the vaccination being made available to those highest at risk, eventually trickling down to be available to the general public.